CDMO competition among biotech companies intensifies; Korean companies all expand factories = South Korea

South Korean pharmaceutical and biotech companies are working to strengthen their production facilities in order to maintain their competitiveness. In response to an increase in orders for outsourced production, Samsung Biologics announced in June that it would open its 4th plant in Songdo (Songdo).